Interactions of drugs with proteins I: Binding of tricyclic thymoleptics to human and bovine plasma proteins
β Scribed by H. J. Weder; M. H. Bickel
- Publisher
- John Wiley and Sons
- Year
- 1970
- Tongue
- English
- Weight
- 317 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
β¦ Synopsis
Data on the binding of imipramine, desipramine, and 3-chlorodesmethylimipramine to plasma proteins have been obtained over a wide range of ligand concentration using a modified equilibrium dialysis technique. Plasma proteins other than albumin do not appreciably contribute to complex formation with the drugs studied. Fifty-nine percent imipramine is bound to albumin in the plasma level range reached under therapeutic conditions. However, the association constants of the complex is low. Species differences in the binding capacity of albumin were observed. Apparently, atypical binding behavior was disclosed for desipramine and 3-chlorodesmethylimipramine. A binding model is discussed, and values of binding parameters are given.
π SIMILAR VOLUMES
The binding of racemic zopiclone (ZOP) and of its two enantiomers to plasma proteins, albumin and β£1-acid glycoprotein were compared. Our work shows that the binding of ZOP to human plasma proteins is stereoselective. The total plasma protein binding percentages were 79.3 Β± 5.5%, 83.8 Β± 5.2%, and 75
The in vitro binding of RS-chlorpheniramine to human proteins was studied by equilibrium dialysis. The binding to total plasma proteins and to individual albumin and β£-glycoprotein acid is stereoselective. (+)S-chlorpheniramine is more extensively bound than its antipode to total plasma proteins (38